CNS chemokines, cytokines, and dendritic cells in autoimmune demyelination

https://doi.org/10.1016/j.jns.2004.10.014Get rights and content

First page preview

First page preview
Click to open first page preview

References (67)

  • R. Martin et al.

    Immunological aspects of demyelinating diseases

    Annu. Rev. Immunol.

    (1992)
  • F. Mokhtarian et al.

    Adoptive transfer of myelin basic protein-sensitized T cells produces chronic relapsing demyelinating disease in mice

    Nature

    (1984)
  • S.S. Zamvil et al.

    The T lymphocyte in experimental allergic encephalomyelitis

    Annu. Rev. Immunol.

    (1990)
  • D.S. Linthicum et al.

    Acute autoimmune encephalomyelitis in mice. II: Susceptibility is controlled by the combination of H-2 and histamine sensitization genes

    J. Exp. Med.

    (1982)
  • P. Rao et al.

    Experimental autoimmune encephalomyelitis

    Methods Mol. Med.

    (2004)
  • C.B. Pettinelli et al.

    Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: requirement for Lyt 1+ 2− T lymphocytes

    J. Immunol.

    (1981)
  • V.K. Kuchroo et al.

    Induction of experimental allergic encephalomyelitis by myelin proteolipid-protein-specific T cell clones and synthetic peptides

    Pathobiology

    (1991)
  • S. Zamvil et al.

    T-cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination

    Nature

    (1985)
  • M.K. Waldor et al.

    Reversal of experimental allergic encephalomyelitis with monoclonal antibody to a T-cell subset marker

    Science

    (1985)
  • D. Cohen et al.

    Class II HLA-DC beta-chain DNA restriction fragments differentiate among HLA-DR2 individuals in insulin-dependent diabetes and multiple sclerosis

    Proc. Natl. Acad. Sci. U. S. A.

    (1984)
  • B. Bielekova et al.

    Encephalitogenic potential of the myelin basic protein peptide (amino acids 83–99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand

    Nat. Med.

    (2000)
  • T.R. Mosmann et al.

    TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties

    Annu. Rev. Immunol.

    (1989)
  • D.J. Cua et al.

    Self-antigen-induced Th2 responses in experimental allergic encephalomyelitis (EAE)-resistant mice. Th2-mediated suppression of autoimmune disease

    J. Immunol.

    (1995)
  • A. Khoruts et al.

    Neuroantigen-specific Th2 cells are inefficient suppressors of experimental autoimmune encephalomyelitis induced by effector Th1 cells

    J. Immunol.

    (1995)
  • M.B. Powell et al.

    Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-specific T cell clones correlates with encephalitogenicity

    Int. Immunol.

    (1990)
  • M.K. Kennedy et al.

    Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery

    J. Immunol.

    (1992)
  • A. Windhagen et al.

    Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions

    J. Exp. Med.

    (1995)
  • C.D. Rohowsky-Kochan et al.

    Cytokine secretion profile of myelin basic protein-specific T cells in multiple sclerosis

    Mult. Scler.

    (2000)
  • F.D. Lublin et al.

    Monoclonal anti-gamma interferon antibodies enhance experimental allergic encephalomyelitis

    Autoimmunity

    (1993)
  • H. Heremans et al.

    Chronic relapsing experimental autoimmune encephalomyelitis (CREAE) in mice: enhancement by monoclonal antibodies against interferon-gamma

    Eur. J. Immunol.

    (1996)
  • I.A. Ferber et al.

    Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE)

    J. Immunol.

    (1996)
  • M. Krakowski et al.

    Interferon-gamma confers resistance to experimental allergic encephalomyelitis

    Eur. J. Immunol.

    (1996)
  • B.M. Segal et al.

    An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease

    J. Exp. Med.

    (1998)
  • Cited by (33)

    • Intranasal delivery of stem cells as therapy for central nervous system disease

      2015, Experimental and Molecular Pathology
      Citation Excerpt :

      A cautionary note should therefore be sounded regarding the use of hyaluronidase in i.n. stem cell treatment. Given that transduction of BM-NSCs with CCR5, a chemokine receptor for CCL3, CCL4, and CCL5, all of which are increased in the inflamed foci of EAE mice (Segal, 2005), greatly increased the speed and numbers of stem cells migrating to EAE foci after i.v. injection (Yang et al., 2012), this approach might also improve the migration efficacy of i.n. stem cell administration. PD is a chronic CNS degenerative disorder, whose pathogenesis includes aging, oxidative stress and neuroinflammation (Gao et al., 2003; Takahashi and Wakabayashi, 2005).

    • Neurotrophin 3 transduction augments remyelinating and immunomodulatory capacity of neural stem cells

      2014, Molecular Therapy
      Citation Excerpt :

      In the CNS, infiltrating autoreactive T cells, macrophages, and dendritic cells, as well as activated microglia and astrocytes, produce proinflammatory cytokines such as IFN-γ, TNF-α, IL-17, and IL-23, and promote cell-mediated immunity.1,2 Conversely, immunoregulatory cytokines such as IL-4, IL-10, TGF-β and IL-27 may be protective.30,31 Importantly, an immunomodulatory effect of NT-3 has been suggested because it induces Th2 cells to produce IL-418 and suppresses CFA-induced inflammatory hyperalgesia39 and experimental trinitrobenzene sulfonic acid-induced colitis.40

    • Immune regulation of multiple sclerosis

      2014, Handbook of Clinical Neurology
      Citation Excerpt :

      The specific functional effect of the individual cytokines depends on intracellular signaling events that are triggered by the binding of cytokines to their specific receptor. Their pleotropism and redundancy make a simple statement about the function of individual cytokines difficult, although studies in knockout mice have helped to clarify the physiologic role of certain cytokines (Perry et al., 2005; Platanias, 2005; Segal, 2005). The burgeoning family of chemoattractant cytokines, so-called chemokines, comprises a large and diverse group of 8–10 kDa proteins that display between two and four NH2-terminal cystein amino acid residues.

    View all citing articles on Scopus
    View full text